Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KKR & Co Inc (KKR) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

KKR & Co IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

KKR & Co Inc vs Health Care Select Sector SPDR Fund — how do they compare? KKR & Co Inc trades at $91.07 (market cap $80.39B), while Health Care Select Sector SPDR Fund trades at $170.79 (market cap $43.48B). The key difference: KKR & Co Inc is the larger of the two by market cap, and KKR & Co Inc pays a 0.87% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold KKR & Co Inc for 67 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

KKRXLV
Market Cap
$80.39B$43.48B
Volume
6,517,70511,121,431
Sector
Financials—
52-Week High
$142.75$175.68
52-Week Low
$83.88$141.95
Typical Hold Time
67 Days100 Days
Enterprise Value
$2.95B—
Dividend Yield
0.87%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KKR & Co Inc

KKR trades at $90.95, up 1.43% on the day, with strong analyst support showing 24 buy ratings and a $123.30 consensus price target. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed. Technical indicators are bearish overall, with RSI levels suggesting potential oversold conditions. The company maintains solid profitability with 14.97% net income margin and continues active portfolio management through recent acquisitions and divestitures.

The investment case for KKR appears favorable given the significant upside to analyst targets and strong institutional support. However, investors face risks from volatile cash flows, high debt levels, and market-sensitive revenue streams. The upcoming Q3 2026 earnings report on November 9 will be crucial for validating current valuation metrics.

Health Care Select Sector SPDR Fund

XLV trades at $170.81, up 1.18% with a bearish technical signal from moving averages. The ETF's low 0.08% expense ratio and healthcare sector diversification provide defensive positioning amid market volatility. Recent options activity shows increased put volume, indicating some investor caution despite healthcare's traditional defensive characteristics during economic uncertainty.

Healthcare sector ETFs like XLV offer defensive exposure with potential upside from demographic trends and innovation. Key risks include political volatility around healthcare policy and concentration in large-cap US stocks. The ETF's cost efficiency and sector positioning make it attractive for long-term investors seeking healthcare exposure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KKR
100% Buy0% Sell
Avg holding period · 67 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

About KKR & Co Inc

KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.

Read more on KKR →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →